![Low percentage of free prostate-specific antigen (PSA) is a strong predictor of later detection of prostate cancer among Japanese men with serum levels of total PSA of 4.0 ng/mL or less. Low percentage of free prostate-specific antigen (PSA) is a strong predictor of later detection of prostate cancer among Japanese men with serum levels of total PSA of 4.0 ng/mL or less.](https://d3i71xaburhd42.cloudfront.net/bbc5bbcef53a29466addccfb1a86dca2e6a5abe5/2-Table1-1.png)
Low percentage of free prostate-specific antigen (PSA) is a strong predictor of later detection of prostate cancer among Japanese men with serum levels of total PSA of 4.0 ng/mL or less.
![SciELO - Brasil - Prognosis of patients with prostate cancer and middle range prostate - specific antigen levels of 20 – 100 ng / mL Prognosis of patients with prostate cancer and SciELO - Brasil - Prognosis of patients with prostate cancer and middle range prostate - specific antigen levels of 20 – 100 ng / mL Prognosis of patients with prostate cancer and](https://minio.scielo.br/documentstore/1677-6119/jVxLkMSNXSmzhDyDd34Kgvd/97855423eadaa475aa2bff26d9ae03085ce47923.jpg)
SciELO - Brasil - Prognosis of patients with prostate cancer and middle range prostate - specific antigen levels of 20 – 100 ng / mL Prognosis of patients with prostate cancer and
![SciELO - Brasil - Prognosis of patients with prostate cancer and middle range prostate - specific antigen levels of 20 – 100 ng / mL Prognosis of patients with prostate cancer and SciELO - Brasil - Prognosis of patients with prostate cancer and middle range prostate - specific antigen levels of 20 – 100 ng / mL Prognosis of patients with prostate cancer and](https://minio.scielo.br/documentstore/1677-6119/jVxLkMSNXSmzhDyDd34Kgvd/11234766ac4c4efdc740ea8c07f31e2138c75d3c.jpg)
SciELO - Brasil - Prognosis of patients with prostate cancer and middle range prostate - specific antigen levels of 20 – 100 ng / mL Prognosis of patients with prostate cancer and
![Men presenting with prostate‐specific antigen (PSA) values of over 100 ng/mL - Ang - 2016 - BJU International - Wiley Online Library Men presenting with prostate‐specific antigen (PSA) values of over 100 ng/mL - Ang - 2016 - BJU International - Wiley Online Library](https://bjui-journals.onlinelibrary.wiley.com/cms/asset/3efd81b2-6a2a-4897-acde-b2c39477a6ba/bju13411-fig-0007-m.jpg)
Men presenting with prostate‐specific antigen (PSA) values of over 100 ng/mL - Ang - 2016 - BJU International - Wiley Online Library
![Association between PSA values and surveillance quality after prostate cancer surgery - Chapman - 2019 - Cancer Medicine - Wiley Online Library Association between PSA values and surveillance quality after prostate cancer surgery - Chapman - 2019 - Cancer Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/1ce96ee1-a195-4e13-9b59-9f1299abe922/cam42663-fig-0002-m.jpg)
Association between PSA values and surveillance quality after prostate cancer surgery - Chapman - 2019 - Cancer Medicine - Wiley Online Library
![PDF] Diagnostic Role of Serum Free-to-Total Prostate Specific Antigen (PSA) Ratio in Prostate Cancer with Serum Total Concentration of PSA below 4 ng/mL. | Semantic Scholar PDF] Diagnostic Role of Serum Free-to-Total Prostate Specific Antigen (PSA) Ratio in Prostate Cancer with Serum Total Concentration of PSA below 4 ng/mL. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/251be2484ab726805c25860ba5917364701380f4/2-Table1-1.png)
PDF] Diagnostic Role of Serum Free-to-Total Prostate Specific Antigen (PSA) Ratio in Prostate Cancer with Serum Total Concentration of PSA below 4 ng/mL. | Semantic Scholar
![Clinical Issues for Prostate-Specific Antigen Screening: A Narrative Review - European Medical Journal Clinical Issues for Prostate-Specific Antigen Screening: A Narrative Review - European Medical Journal](https://emj.emg-health.com/wp-content/uploads/sites/2/2018/12/Table-2-Characteristics-of-three-major.jpg)
Clinical Issues for Prostate-Specific Antigen Screening: A Narrative Review - European Medical Journal
![Patient no. 7 with a rising PSA level to 1.3 ng/ml. In the past, the... | Download Scientific Diagram Patient no. 7 with a rising PSA level to 1.3 ng/ml. In the past, the... | Download Scientific Diagram](https://www.researchgate.net/publication/277412952/figure/fig2/AS:391983605534721@1470467582705/Patient-no-7-with-a-rising-PSA-level-to-13-ng-ml-In-the-past-the-patient-had-left.png)
Patient no. 7 with a rising PSA level to 1.3 ng/ml. In the past, the... | Download Scientific Diagram
![JCM | Free Full-Text | Prostate Cancer Screening with PSA: Ten Years' Experience of Population Based Early Prostate Cancer Detection Programme in Lithuania JCM | Free Full-Text | Prostate Cancer Screening with PSA: Ten Years' Experience of Population Based Early Prostate Cancer Detection Programme in Lithuania](https://www.mdpi.com/jcm/jcm-09-03826/article_deploy/html/images/jcm-09-03826-g001.png)
JCM | Free Full-Text | Prostate Cancer Screening with PSA: Ten Years' Experience of Population Based Early Prostate Cancer Detection Programme in Lithuania
![JCM | Free Full-Text | The Association between Prostate-Specific Antigen Velocity (PSAV), Value and Acceleration, and of the Free PSA/Total PSA Index or Ratio, with Prostate Conditions JCM | Free Full-Text | The Association between Prostate-Specific Antigen Velocity (PSAV), Value and Acceleration, and of the Free PSA/Total PSA Index or Ratio, with Prostate Conditions](https://www.mdpi.com/jcm/jcm-09-03400/article_deploy/html/images/jcm-09-03400-g001.png)
JCM | Free Full-Text | The Association between Prostate-Specific Antigen Velocity (PSAV), Value and Acceleration, and of the Free PSA/Total PSA Index or Ratio, with Prostate Conditions
![Improving the diagnosis of prostate cancer by telomerase-positive circulating tumor cells: A prospective pilot study - eClinicalMedicine Improving the diagnosis of prostate cancer by telomerase-positive circulating tumor cells: A prospective pilot study - eClinicalMedicine](https://www.thelancet.com/cms/attachment/fbc9fb93-c826-43a7-b92a-ac0d1359335c/gr1_lrg.jpg)
Improving the diagnosis of prostate cancer by telomerase-positive circulating tumor cells: A prospective pilot study - eClinicalMedicine
![Frontiers | Influence of Tumor Burden on Serum Prostate-Specific Antigen in Prostate Cancer Patients Undergoing Radical Prostatectomy Frontiers | Influence of Tumor Burden on Serum Prostate-Specific Antigen in Prostate Cancer Patients Undergoing Radical Prostatectomy](https://www.frontiersin.org/files/Articles/656444/fonc-11-656444-HTML/image_m/fonc-11-656444-t001.jpg)
Frontiers | Influence of Tumor Burden on Serum Prostate-Specific Antigen in Prostate Cancer Patients Undergoing Radical Prostatectomy
![Molecular Form Differences Between Prostate-Specific Antigen (PSA) Standards Create Quantitative Discordances in PSA ELISA Measurements | Scientific Reports Molecular Form Differences Between Prostate-Specific Antigen (PSA) Standards Create Quantitative Discordances in PSA ELISA Measurements | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsrep22050/MediaObjects/41598_2016_Article_BFsrep22050_Fig1_HTML.jpg)